About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Aarti Pharmalabs Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
543748
ISIN Demat
INE0LRU01027
Book Value
208.87
NSE Code
AARTIPHARM
Dividend Yield %
0.59
Market Cap
76279.70
P/E
29.18
EPS
28.84
Face Value
5
BSE
NSE
06-Nov-2025
BSE
NSE
NSE F & O
06-Nov-2025 15:53
BSE
NSE
NSE F & O
Last Price
843.00
Net Change
-1.45
% Change
-0.17%
Prev.Close
844.45
Open
841.65
High
863.55
Low
836.55
Volume
8000
Last Price
843.90
Net Change
-0.7
% Change
-0.08%
Prev.Close
844.60
Open
856.80
High
864.40
Low
837.00
Volume
203433
Value
6832209
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
863.55
52-Week High
971.50
52-Week Low
550.25
Value
171677108.7
Best Buy
0.00
Best Sell
843.90
Best Quantity
0
Sell Quantity
275
Today's Range
864.40
52-Week High
971.00
52-Week Low
557.05
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
275
Price
843.90
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Dividend
50 %
15-Sep-25
Company News
22-09-2025
Aarti Pharmalabs informs ...
03-09-2025
Aarti Pharmalabs inaugura...
29-08-2025
Aarti Pharmalabs informs ...
17-07-2025
Aarti Pharmalabs informs ...
18-06-2025
Aarti Pharmalabs informs ...
29-04-2025
Aarti Pharmalabs informs ...
25-04-2025
Aarti Pharmalab informs a...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.
